Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Exhibit 1.1
- 3.1 Exhibit 3.1
- 3.2 Exhibit 3.2
- 3.3 Exhibit 3.3
- 4.1 Exhibit 4.1
- 4.2 Exhibit 4.2
- 4.4 Exhibit 4.4
- 5.1 Exhibit 5.1
- 10.1 EXHIBIT10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 23.1 Exhibit 23.1
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
Associated filings
LVAC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated October 1, 2021, relating to the financial statements of LAVA Medtech Acquisition Corp. as of April 20, 2021, and for the period from March 31, 2021 (inception) through April 20, 2021. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company’s ability to continue as a going concern. We also consent to the reference to our Firm under the caption “Experts” in the above noted Registration Statement.
/s/ Citrin Cooperman & Company, LLP
New York, New York
October 1, 2021